75 related articles for article (PubMed ID: 23116185)
1. Use of systemic glucocorticoids and the risk of colorectal cancer.
Ostenfeld EB; Erichsen R; Thorlacius-Ussing O; Riis AH; Sørensen HT
Aliment Pharmacol Ther; 2013 Jan; 37(1):146-52. PubMed ID: 23116185
[TBL] [Abstract][Full Text] [Related]
2. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
Johannesdottir SA; Horváth-Puhó E; Dekkers OM; Cannegieter SC; Jørgensen JO; Ehrenstein V; Vandenbroucke JP; Pedersen L; Sørensen HT
JAMA Intern Med; 2013 May; 173(9):743-52. PubMed ID: 23546607
[TBL] [Abstract][Full Text] [Related]
3. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
4. Use of Glucocorticoids and Risk of Community-Acquired Staphylococcus aureus Bacteremia: A Population-Based Case-Control Study.
Smit J; Kaasch AJ; Søgaard M; Thomsen RW; Nielsen H; Frøslev T; Schønheyder HC
Mayo Clin Proc; 2016 Jul; 91(7):873-80. PubMed ID: 27289410
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study.
Robertson DJ; Larsson H; Friis S; Pedersen L; Baron JA; Sørensen HT
Gastroenterology; 2007 Sep; 133(3):755-60. PubMed ID: 17678921
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors and the risk of colorectal cancer.
van Soest EM; van Rossum LG; Dieleman JP; van Oijen MG; Siersema PD; Sturkenboom MC; Kuipers EJ
Am J Gastroenterol; 2008 Apr; 103(4):966-73. PubMed ID: 18070237
[TBL] [Abstract][Full Text] [Related]
7. Exposure to bisphosphonates and risk of colorectal cancer: a population-based nested case-control study.
Singh H; Nugent Z; Demers A; Mahmud S; Bernstein C
Cancer; 2012 Mar; 118(5):1236-43. PubMed ID: 21823104
[TBL] [Abstract][Full Text] [Related]
8. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study.
Velayos FS; Loftus EV; Jess T; Harmsen WS; Bida J; Zinsmeister AR; Tremaine WJ; Sandborn WJ
Gastroenterology; 2006 Jun; 130(7):1941-9. PubMed ID: 16762617
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study.
Christiansen CF; Christensen S; Mehnert F; Cummings SR; Chapurlat RD; Sørensen HT
Arch Intern Med; 2009 Oct; 169(18):1677-83. PubMed ID: 19822824
[TBL] [Abstract][Full Text] [Related]
10. Statin use and risk of colorectal cancer.
Coogan PF; Smith J; Rosenberg L
J Natl Cancer Inst; 2007 Jan; 99(1):32-40. PubMed ID: 17202111
[TBL] [Abstract][Full Text] [Related]
11. Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study.
Sørensen GV; Cronin-Fenton DP; Sørensen HT; Ulrichsen SP; Pedersen L; Lash TL
Breast Cancer Res; 2012 Feb; 14(1):R21. PubMed ID: 22305057
[TBL] [Abstract][Full Text] [Related]
12. Smoking and colorectal cancer: different effects by type of cigarettes?
Lüchtenborg M; White KK; Wilkens L; Kolonel LN; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1341-7. PubMed ID: 17626999
[TBL] [Abstract][Full Text] [Related]
13. Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women.
Wei EK; Giovannucci E; Selhub J; Fuchs CS; Hankinson SE; Ma J
J Natl Cancer Inst; 2005 May; 97(9):684-92. PubMed ID: 15870439
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
Jess T; Loftus EV; Velayos FS; Winther KV; Tremaine WJ; Zinsmeister AR; Scott Harmsen W; Langholz E; Binder V; Munkholm P; Sandborn WJ
Am J Gastroenterol; 2007 Apr; 102(4):829-36. PubMed ID: 17222314
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
16. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study.
Sadr-Azodi O; Mattsson F; Bexlius TS; Lindblad M; Lagergren J; Ljung R
JAMA Intern Med; 2013 Mar; 173(6):444-9. PubMed ID: 23440105
[TBL] [Abstract][Full Text] [Related]
17. Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden.
Pritchard RS; Baron JA; Gerhardsson de Verdier M
Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):897-900. PubMed ID: 8922297
[TBL] [Abstract][Full Text] [Related]
18. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
Wei EK; Giovannucci E; Fuchs CS; Willett WC; Mantzoros CS
J Natl Cancer Inst; 2005 Nov; 97(22):1688-94. PubMed ID: 16288122
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: results from the Netherlands Cohort Study.
Weijenberg MP; Aardening PW; de Kok TM; de Goeij AF; van den Brandt PA
Mutat Res; 2008 Mar; 652(1):54-64. PubMed ID: 18296105
[TBL] [Abstract][Full Text] [Related]
20. Preadmission use of systemic glucocorticoids and 30-day mortality following bleeding peptic ulcer: a population-based cohort study.
Olsen M; Christensen S; Riis A; Thomsen RW
Am J Ther; 2010; 17(1):23-9. PubMed ID: 19531935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]